Schizophrenia News and Research

Latest Schizophrenia News and Research

Once-daily single-tablet HIV therapy developed

A single tablet containing four antiviral agents may be an effective initial once-daily therapy for adults infected with HIV, shows phase III clinical research.

16 Jul 2012

Treatment deteriorates giant cell arteritis imaging sensitivity

Patients with suspected giant cell arteritis should undergo imaging before or as soon as possible after treatment has started to minimize the chance of a false–negative result, advise German researchers.

16 Jul 2012

Psychotic depression now fulfills the criteria for a valid psychiatric syndrome

The number of studies reporting significant and clinically relevant differences between psychotic depression (PD) and non-PD has increased considerably over the past decades. This summary of the current evidence suggests that PD now fulfils the criteria for a valid psychiatric syndrome.

14 Jul 2012

Infants with food allergies exhibit high rate of reactions over time

Infants with documented or likely milk or egg allergies experience a high number of reactions caused by accidental and nonaccidental exposure, results of a three-year observational study demonstrate.

13 Jul 2012

Adding functional skills training to CRT improves schizophrenia functioning

Adding functional skills training to cognitive remediation therapy significantly improves functional competence and real-world behavior in patients with schizophrenia, show study findings.

13 Jul 2012

Altered immune function in relatives of schizophrenia patients

Schizophrenia patients and their unaffected first-degree relatives exhibit immune system alterations compared with mentally healthy individuals, researchers report.

12 Jul 2012

Potassium channel KIR4.1 clue to multiple sclerosis

The potassium channel KIR4.1 is a potential immune target in certain patients with multiple sclerosis, report researchers in TheNew England Journal of Medicine.

12 Jul 2012

US hospitals fail to meet critical esophagectomy benchmark

A study has shown that most US hospitals fail to ensure that surgeons examine at least 15 lymph nodes during esophagectomy for cancer, and are therefore failing to meet guideline recommendations for detecting metastases.

12 Jul 2012

Overweight, obesity prevalent in psychiatric inpatients

Most inpatients with psychiatric disorders are overweight or obese, say Australian researchers who urge closer monitoring of the physical health of patients with mental illnesses.

12 Jul 2012

Researchers identify set of laboratory-based biomarkers that aid in diagnosis of schizophrenia

In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.

12 Jul 2012

Novel molecular mechanism responsible for most important symptom of major depression

Stanford University School of Medicine scientists have laid bare a novel molecular mechanism responsible for the most important symptom of major depression: anhedonia, the loss of the ability to experience pleasure.

12 Jul 2012

Thrombopoietin mimetic offers aplastic anemia hope

Eltrombopag significantly improves blood counts in some patients with refractory severe aplastic anemia, suggests research published in The New England Journal of Medicine.

11 Jul 2012

Visual, auditory hallucinations often co-occur in psychosis patients

Visual hallucinations are common in patients with psychosis spectrum disorders and often co-occur with auditory hallucinations, researchers report.

11 Jul 2012

Psychologic well-being reduced in schizophrenia patients

Patients with schizophrenia have significantly lower psychologic well-being compared with mentally healthy individuals, say researchers.

10 Jul 2012

Altered immune function in relatives of schizophrenia patients

Schizophrenia patients and their unaffected first-degree relatives exhibit immune system alterations compared with mentally healthy individuals, researchers report.

10 Jul 2012

Family history of schizophrenia, BD increases autism risk

A history of schizophrenia or bipolar disorder in first-degree relatives is associated with a significantly increased risk for autism spectrum disorders, study results suggest.

10 Jul 2012

Cannabis use may reduce mortality risk in psychosis patients

Cannabis use is associated with reduced mortality risk in patients with psychotic disorders, study results suggest.

10 Jul 2012

Family history of schizophrenia, BD increases autism risk

A history of schizophrenia or bipolar disorder in first-degree relatives is associated with a significantly increased risk for autism spectrum disorders, study results suggest.

10 Jul 2012

Emotion awareness linked to social functioning in schizophrenia

Emotion awareness and regulation deficits are significantly associated with reduced social functioning in patients with schizophrenia, research shows.

10 Jul 2012

ACADI’s pimavanserin may have therapeutic benefits in treatment of ADP

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced results of preclinical studies, which suggest that pimavanserin, ACADIA's proprietary product candidate currently in Phase III development for Parkinson's disease psychosis, also may have therapeutic benefits in the treatment of Alzheimer's disease psychosis (ADP).

10 Jul 2012